The Non-Responder Who Loves the Appliance
A 52-year-old man with severe OSA (baseline AHI 41, ODI 38, nadir 78%) was fitted with a custom MAD after CPAP failure. He has been advanced to near maximum protrusion over four months. He reports excellent adherence, loves the appliance, and says his wife no longer hears snoring. A repeat home sleep study on the appliance shows AHI 24 with ODI 26. He has gained 6 kg since baseline. He refuses to consider CPAP again and asks you to 'just advance it a little more.' He has no dental complications and reports no jaw pain.
1. How do you interpret the discordance between his subjective report and the objective result, and what is your response to the request to advance further?
Read the worked answer
Subjective improvement and spousal report of reduced snoring are real but insufficient endpoints. An AHI of 24 with ODI 26 and a history of a nadir of 78% means he remains at meaningful cardiovascular risk. The weight gain of 6 kg is a plausible contributor to a reduced response, since MAD efficacy can decline with weight gain and worsening baseline severity.
Advancing further is reasonable only if there is remaining protrusion and the patient tolerates it, but it should be framed as a trial with a defined endpoint, not as a fix. Before advancing, confirm he is at or near maximum protrusion and that the appliance is seating correctly. If he is already near maximum, further advancement risks dental and TMJ harm with little expected benefit. The honest conversation is that an appliance reducing AHI from 41 to 24 is a partial response, not adequate control, and that his options include combination therapy, weight management, or revisiting PAP with a different interface. Do not collude with 'just advance it' without a retest plan.
2. What combination and adjunct strategies would you discuss, and how do you sequence them?
Read the worked answer
Options include: (1) combination therapy with the MAD plus PAP, which can allow lower PAP pressures and improve tolerance; (2) weight management, including a structured program or referral for obesity medicine, since his 6 kg gain likely blunted response; (3) positional therapy if his residual events are supine-predominant, which the home study may not have characterized well; and (4) re-evaluation of PAP with a different mask or mode, given that his prior failure may have been interface-related rather than therapy-related.
Sequencing: first, obtain a better characterization of his residual disease, ideally an in-lab study on the appliance to assess position dependence and confirm the home result. In parallel, refer for weight management. If he remains opposed to PAP, discuss combination therapy as a bridge. Advancing the appliance can be tried if there is room, but with a scheduled retest and a pre-agreed definition of success. Document that he was informed of the residual risk.
3. How do you handle the adherence and consent documentation in this case?
Read the worked answer
Document that the patient reports excellent adherence and subjective benefit, and that the objective study shows residual moderate disease. Record the specific numbers and that the patient was informed that snoring reduction does not equal apnea control. Document his refusal of CPAP, the alternatives offered, and the plan for retest. If he declines further workup, note that he understands the residual risk and that he is choosing to continue the appliance as is. Use a shared decision-making note rather than a one-line 'patient happy.' This protects the patient and the clinician and keeps the door open for future escalation.